Influence of vehicle and anterior chamber protein concentration on cyclosporine penetration through the isolated rabbit cornea.

The transcorneal penetration of cyclosporine A has been determined from each of three vehicles across isolated cornea into simulated aqueous humor containing either 50 mg % protein (0.5 mg/ml; as found in a normal eye) or 5000 mg % protein (50 mg/ml; as found in an inflamed eye). Cyclosporine entered the corneal epithelium and stroma/endothelium as well as passed through the cornea from an alpha cyclodextrin vehicle. Entry into the epithelium and stroma/endothelium occurred from an ointment vehicle with limited detectable anterior chamber penetration using 50 mg % protein solution in the anterior chamber. From corn oil vehicle, cyclosporine penetrated across the cornea with a permeability equal to that of alpha cyclodextrin vehicle. The concentration of cyclosporine in both corn oil and ointment vehicles is 8 times greater than that in alpha cyclodextrin vehicle resulting in a flux from corn oil vehicle about 7 or 8 times greater than that seen after alpha cyclodextrin vehicle. The amounts retained in the cornea, however, were relatively low after corn oil compared to cyclodextrin. The penetration of cyclosporine from either the cyclodextrin vehicle or ointment was at least doubled in the presence of 5000 mg % protein in the simulated aqueous humor relative to that seen in 50 mg % protein. This data indicates that the (presumed) absorption and binding of drug by the excess protein in the simulated aqueous humor may have removed free cyclosporine from the solution and sustained a high concentration gradient of free solute across the cornea.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  E. Young,et al.  The effect of cyclosporine in chlamydial eye infection. , 1987, Current eye research.

[2]  M. Belin,et al.  Topical cyclosporine in high-risk corneal transplants. , 1989, Ophthalmology.

[3]  C. Paterson,et al.  Anomalous effects of anti-inflammatory corticosteroids in endotoxin-induced ocular inflammation. , 1984, European journal of pharmacology.

[4]  D. Benezra,et al.  Ocular penetration of cyclosporin A. The rabbit eye. , 1990, Investigative ophthalmology & visual science.

[5]  K. Green,et al.  Benzalkonium Chloride Kinetics in Young and Adult Albino and Pigmented Rabbit Eyes , 1986 .

[6]  M. Sanders,et al.  Cyclosporin A in the treatment of severe Behçet's uveitis. , 1987, British journal of rheumatology.

[7]  C. de Courten,et al.  Ocular penetration of cyclosporin A. III: The human eye. , 1990, The British journal of ophthalmology.

[8]  M. Wiederholt,et al.  Pharmacokinetic of topical cyclosporin A in the rabbit eye. , 1986, Investigative ophthalmology & visual science.

[9]  Kaswan Rl Intraocular penetration of topically applied cyclosporine. , 1988 .

[10]  K. Green,et al.  Aqueous humor dynamics: experimental studies. , 1973, Experimental eye research.

[11]  K. Green,et al.  Rabbit corneal endothelial permeability in the presence and absence of adenosine and glutathione. , 1982, Current eye research.

[12]  B. Gebhardt,et al.  Penetration of topical cyclosporine into the rabbit cornea, aqueous humor, and serum. , 1985, Archives of ophthalmology.

[13]  A. Nakajima,et al.  The effect on the cornea of alpha cyclodextrin vehicle for cyclosporin eye drops. , 1989, Transplantation proceedings.

[14]  K. Green,et al.  Permeability to water of rabbit corneal membranes. , 1969, The American journal of physiology.

[15]  M. Wilson,et al.  Detergent penetration into young and adult rabbit eyes: comparative pharmacokinetics , 1987 .

[16]  T. A. Bell,et al.  Cyclosporin A: tissue levels following topical and systemic administration to rabbits. , 1986, The British journal of ophthalmology.

[17]  D. Benezra,et al.  Ocular penetration of cyclosporine A in the rat eye. , 1990, Archives of ophthalmology.

[18]  S. Burgalassi,et al.  Preparation and evaluation in rabbits of topical solutions containing forskolin. , 1989, Journal of ocular pharmacology.

[19]  J. Menezo,et al.  Penetration of 2% cyclosporin eyedrops into human aqueous humour. , 1989, The British journal of ophthalmology.

[20]  R. Yee,et al.  Topical cyclosporine therapy for ulcerative keratitis associated with rheumatoid arthritis. , 1990, American journal of ophthalmology.

[21]  M. Doane,et al.  Penetration routes of topically applied eye medications. , 1978, American journal of ophthalmology.

[22]  R. Nussenblatt,et al.  Cyclosporine penetration into the anterior chamber and cerebrospinal fluid. , 1985, American journal of ophthalmology.

[23]  Nussenblatt Rb The use of cyclosporine in ocular inflammatory disorders. , 1988 .

[24]  F. Hoffmann,et al.  Lokale Behandlung des Hornhauttransplantates beim Menschen mit Cyclosporin A , 1985 .

[25]  D. Coster,et al.  A comparison of the effects of topical cyclosporine and topical steroid on rabbit corneal allograft rejection. , 1985, Transplantation.

[26]  K. Green,et al.  Rabbit endothelial response to ophthalmic preservatives. , 1977, Archives of ophthalmology.

[27]  T. Starzl,et al.  Fungal Infections After Liver Transplantation. , 1988, Transplantation proceedings.

[28]  D. Ward,et al.  Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops. , 1989, Archives of ophthalmology.

[29]  T. F. Patton,et al.  Importance of the noncorneal absorption route in topical ophthalmic drug delivery. , 1985, Investigative ophthalmology & visual science.

[30]  P. Kulkarni,et al.  Effects of anti-inflammatory and immunosuppressive drugs on the heterolamellar corneal transplantation in rabbits. , 1990, Current eye research.

[31]  K. Eakins,et al.  The effects of prostaglandins on the intraocular pressure of the rabbit , 1969, British journal of pharmacology.

[32]  K. Eakins,et al.  Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye. , 1970, Experimental eye research.

[33]  C. de Courten,et al.  Treatment of endogenous uveitis with cyclosporine A. , 1988, Transplantation proceedings.

[34]  L. Demers,et al.  Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring. , 1987, Clinical Chemistry.

[35]  M. Belin,et al.  Update on topical cyclosporin A. Background, immunology, and pharmacology. , 1990, Cornea.

[36]  D. Duchěne,et al.  Pharmaceutical Uses of Cyclodextrins and Derivatives , 1990 .

[37]  B. Gebhardt,et al.  Topically applied cyclosporine in azone prolongs corneal allograft survival. , 1988, Investigative ophthalmology & visual science.

[38]  K. Green,et al.  Effects of thymoxamine on corneal endothelium. , 1991, Lens and eye toxicity research.

[39]  J. Forrester,et al.  EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. , 1987, Clinical and experimental immunology.

[40]  Y. Pouliquen,et al.  [Cyclosporin A eyedrops in the prevention of high-risk corneal graft rejection. II. Postoperative clinical results]. , 1987, Journal francais d'ophtalmologie.